Gene Mutations Targeted in Individualized Therapy of Dementia, ALS

Scientists at Johns Hopkins have developed new drugs that seem to stop the destructive impact of a gene mutation behind two incurable neurodegenerative diseases, amyotrophic lateral sclerosis (ALS) and dementia. In a series of test tube studies, researchers believe that they are closer to creating individualized therapies for dementia and ALS. Click here to read details.